VTRS Trademark

Trademark Overview

On Friday, May 27, 2022, a trademark application was filed for VTRS with the United States Patent and Trademark Office. The USPTO has given the VTRS trademark a serial number of 97432112. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, December 3, 2024. This trademark is owned by Mylan Inc.. The VTRS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders, pain

General Information

Serial Number97432112
Word MarkVTRS
Filing DateFriday, May 27, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders, pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2022
Primary Code005
First Use Anywhere DateTuesday, November 12, 2024
First Use In Commerce DateTuesday, November 12, 2024

Trademark Owner History

Party NameMylan Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMylan Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317

Trademark Events

Event DateEvent Description
Thursday, June 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 17, 2023ASSIGNED TO EXAMINER
Tuesday, May 31, 2022NEW APPLICATION ENTERED
Thursday, February 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 16, 2023SOU EXTENSION 1 FILED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 23, 2024SOU EXTENSION 2 FILED
Tuesday, June 25, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 25, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, June 25, 2024PETITION TO REVIVE-GRANTED
Tuesday, June 25, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 12, 2024USE AMENDMENT FILED
Tuesday, August 20, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 21, 2024SOU EXTENSION 2 GRANTED
Saturday, November 16, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 12, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, December 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 3, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

vtrs disorders diseases neurological pain system nervous preparations treatment central pharmaceutical